LIGAND PHARMACEUTICALS INCORPORATED: accounts_receivable
| Value | {"amount": 36003000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2023-09-30) |
| Status | current |
| Entity | LIGAND PHARMACEUTICALS INCORPORATED |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:53:36.541691+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/686ca9fc-2c55-4277-8f3d-14d478a481d5
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000886163-23-000086Retrieved: 2026-08-19T08:53:36.541691+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000886163/accounts-receivable/2023-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/686ca9fc-2c55-4277-8f3d-14d478a481d5
History
- no predecessors — first report